Your search matched 17 results
Nearly 70 speakers took the stage over two days to inspire the crowd at the Patient USA conference.
Emmanuel Fombu, Medical Director at Novartis was definitely one of the most dynamic presenters at Patient USA.
Each year, around 3.6 million patients across the USA miss at least one appointment due to lack of access to transportation.
Frank Spinelli, Medical Director of Patient Affairs at US ViiV Healthcare started his career in private practice.
In 2015, Novartis made a bold declaration for what patients should expect from the company in areas ranging from clinical trials to access to medicines.
Martin Mendoza, Director of Extramural Research, Office of Minority Health at the FDA, shared a perspective on inclusion and diversity in clinical trials.
Anjali Trasy, the Global Head, of Patient Engagement Strategy at Sanofi asked has patient engagement come of age?
Pharmaceutical companies across the globe are finding the channels through which they can get desperately needed treatments to patients in need at humane prices.
Since the fall of 2015, and against a backdrop of harsh media attention to pharmaceutical pricing, patient advocacy groups that form partnerships with pharma companies have received negative coverage in The New York Times, USA Today and other publications.
Ernest Quintana knew he had long suffered from a deadly lung disease when he was rushed to the hospital, but the news of his imminent death still profoundly shocked him and his family—not because of its grimness but who delivered it: a robot.
The general perception is that the healthcare industry has lagged behind with innovations using technology and service design.
It’s Not Easy Eating Greens | Blog
In the largest multi-state food-borne E. coli outbreak since 2006, at least 84 people across 19 states have been infected with E. coli from romaine lettuce in the past month.
Top 10 Posts of 2017 | Blog
Join us in celebrating our best ofs, tops and faves in this list of the top 10 posts of 2017.
Our team kept an eye on a number of stories about opioid “pledges,” top-line data communications and, as always, drug pricing.
This edition of Medical Science Moments features research and other news on: CRISPR gene editing to treat human diseases; New approvals for CAR-T cell therapies; Stem cell therapy for heart failure
This edition of Medical Science Moments features highlights from the recent ASCO conference.
Headlines about the Senate Finance Committee’s bill are everywhere.